The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Open accessAbstract
The eye is a privileged site that cannot tolerate destructive inflammatory responses. Inflammatory cells entering the anterior chamber of the eye in response to viral infection underwent apoptosis that was dependent on Fas (CD95)-Fas ligand (FasL) and produced no tissue damage. In contrast, viral infection in gld mice, which lack functional FasL, resulted in an inflammation and invasion of ocular tissue without apoptosis. Fas-positive but not Fas-negative tumor cells were killed by apoptosis when placed within isolated anterior segments of the eyes of normal but not FasL-negative mice. FasL messenger RNA and protein were detectable in the eye. Thus, Fas-FasL interactions appear to be an important mechanism for the maintenance of immune privilege.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
Self-citationSmith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., & Owen, J. J. T. (1989) · Nature · doi:10.1038/337181a0 · Cited by 1,133
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
Singer, G. G., & Abbas, A. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90067-1 · Cited by 691
Cited by
Items 101–135 of 135
Microglia induce CD4 T lymphocyte final effector function and death.
Ford, A. L., Foulcher, E., Lemckert, F. A., & Sedgwick, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1737 · Cited by 262
T Cells Deficient in Inositol 1,4,5-Trisphosphate Receptor Are Resistant to Apoptosis
Jayaraman, T., & Marks, A. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3005 · Cited by 257
Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment
Du, L., Kijlstra, A., & Yang, P. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.02.002 · Cited by 254
Taylor, A. W. (2009) · Eye · doi:10.1038/eye.2008.382 · Cited by 253
Hierarchical Control of Lymphocyte Survival
Boise, L. H., & Thompson, C. B. (1996) · Science · doi:10.1126/science.274.5284.67 · Cited by 253
The role of FasL-induced apoptosis in immune privilege
Griffith, T. S., & Ferguson, T. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)81663-5 · Cited by 253
Self-citationExpression of Fas ligand in liver metastases of human colonic adenocarcinomas
Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K. J., & Takahashi, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6420 · Cited by 252
Fas Ligand: A Sensor for DNA Damage Critical in Skin Cancer Etiology
Hill, L. L., Ouhtit, A., Loughlin, S. M., Kripke, M. L., Ananthaswamy, H. N., & Owen-Schaub, L. B. (1999) · Science · doi:10.1126/science.285.5429.898 · Cited by 245
The Fas counterattack: Cancer as a site of immune privilege
O’Connell, J., Bennett, M. W., O’Sullivan, G. C., Collins, J. K., & Shanahan, F. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01382-6 · Cited by 232
Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD
Algvere, P. V., Gouras, P., & Dafgård Kopp, E. (1999) · European Journal of Ophthalmology · doi:10.1177/112067219900900310 · Cited by 219
STEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208
Uckan, D. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.8.655 · Cited by 206
Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Calippe, B., Augustin, S., Beguier, F., Charles-Messance, H., Poupel, L., Conart, J.-B., Hu, S. J., Lavalette, S., Fauvet, A., Rayes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.006 · Cited by 168
Headen, D. M., Woodward, K. B., Coronel, M. M., Shrestha, P., Weaver, J. D., Zhao, H., Tan, M., Hunckler, M. D., Bowen, W. S., Johnson, C. T., et al. (2018) · Nature Materials · doi:10.1038/s41563-018-0099-0 · Cited by 175
(2001) · PubMed · Cited by 130
Innate Immune Response in Retinal Homeostasis and Inflammatory Disorders
Murakami, Y., Ishikawa, K., Nakao, S., & Sonoda, K.-H. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100778 · Cited by 125
Sata, M., Suhara, T., & Walsh, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.309 · Cited by 118
Immune response following intraocular delivery of recombinant viral vectors
Bennett, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302030 · Cited by 111
Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion
Barkalow, F., Goodman, M., Gerritsen, M., & Mayadas, T. (1996) · Blood · doi:10.1182/blood.v88.12.4585.bloodjournal88124585 · Cited by 110
Platelets: The missing link between the blood and brain?
Leiter, O., & Walker, T. L. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101695 · Cited by 103
Immune regulation and the eye.
Stein-Streilein, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.002 · Cited by 99
Tumor counterattack: Fact or fiction?
Igney, F. H., & Krammer, P. H. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0680-7 · Cited by 98
Sonoda, K., Sakamoto, T., Qiao, H., Hisatomi, T., Oshima, T., Tsutsumi‐Miyahara, C., Exley, M., Balk, S. P., Taniguchi, M., & Ishibashi, T. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02239.x · Cited by 87
Loss of Fas-Ligand Expression in Mouse Keratinocytes during UV Carcinogenesis
Ouhtit, A., Gorny, A., Muller, H. K., Hill, L. L., Owen-Schaub, L., & Ananthaswamy, H. N. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64836-5 · Cited by 82
Kumar, S. R. P., Hoffman, B. E., Terhorst, C., de Jong, Y. P., & Herzog, R. W. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.014 · Cited by 83
“Several liver-resident APCs (including liver sinusoidal endothelial cell and Kupffer cells) have been implemented in establishing peripheral immune tolerance,(63,64) and various cytokines and signaling pathways have also been proposed to mediate liver tolerance.(4,14,34,35) Again, inhibitory signals provided by PD-1 a…”
BackgroundPender, M. P. (1999) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.1999.00818.x · Cited by 77
Hill, L. L., Shreedhar, V. K., Kripke, M. L., & Owen-Schaub, L. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1285 · Cited by 75
Ultraviolet Light-Induced Immune Tolerance Is Mediated via the Fas/Fas-Ligand System
Schwarz, A., Grabbe, S., Grosse-Heitmeyer, K., Roters, B., Riemann, H., Luger, T. A., Trinchieri, G., & Schwarz, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4262 · Cited by 73
Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway
Charles, R., Chou, H.-S., Wang, L., Fung, J. J., Lu, L., & Qian, S. (2013) · Transplantation · doi:10.1097/tp.0b013e318294caae · Cited by 72
Krishnan, A., Fei, F., Jones, A., Busto, P., Marshak-Rothstein, A., Ksander, B. R., & Gregory-Ksander, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601488 · Cited by 68
Review of Ocular Immune Privilege in the Year 2010: Modifying the Immune Privilege of the Eye
Hori, J., Vega, J. L., & Masli, S. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.512696 · Cited by 64
“1997;18: 240–244 [37] Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA.”
Herndon, J. M., Stuart, P. M., & Ferguson, T. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4098 · Cited by 38
Self-citationWoodward, K. B., Zhao, H., Shrestha, P., Batra, L., Tan, M., Grimany-Nuno, O., Bandura-Morgan, L., Askenasy, N., Shirwan, H., & Yolcu, E. S. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15747 · Cited by 35
Risk mitigation of immunogenicity: a key to personalized retinal gene therapy
Varin, J., Morival, C., Maillard, N., Adjali, O., & Cronin, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312818 · Cited by 19
Metadata
- Authors
- Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A.
- Venue
- Science
- Published
- 1995-11-17
- Volume
- 270
- Issue
- 5239
- Pages
- 1189-1192
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1978018492
- Cited by
- 2,005
- References
- 20
- FWCI
- 42.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.